Studies have increasingly pointed out the role of TP53TG1 in the progression of various cancers, where its expression is altered in several tumors, including hepatocellular carcinoma, breast cancer, gastric cancer, non-small cell lung cancer, colorectal cancer, and glioma. Here, TP53TG1 is linked to hepatocellular carcinoma.